FDA approves ANDA for Lannett Diethylpropion HCl tablets
Diethylpropion HCl, like many anti-obesity drugs, is primarily sold to bariatric clinics, the company said. Lannett president and CEO Arthur P Bedrosian said the approval would add to
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.
AIN457 is a fully human, targeted monoclonal antibody that specifically binds to and neutralizes interleukin-17A (IL-17A), an inflammatory cytokine implicated in many immune-mediated diseases, including psoriasis. The three
LDX is a chemically formulated long-acting prescription-only medicine, prodrug of dexamfetamine. The active-controlled, double-blind, dose-optimisation, parallel-group, multicentre, randomised study, which enrolled 336 children and adolescents aged 6 to17